Picture loading failed.

Anti-MET therapeutic antibody (Pre-made Onartuzumab biosimilar,Fab + di-Fc) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Onartuzumab is a humanized monoclonal antibody designed for the treatment of advanced non-small-cell lung cancer.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-401-1mg 1mg 3090
GMP-Bios-ab-401-10mg 10mg 21890
GMP-Bios-ab-401-100mg 100mg 148000
GMP-Bios-ab-401-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-MET therapeutic antibody (Pre-made Onartuzumab biosimilar,Fab + di-Fc)
INN Name Onartuzumab
TargetMET
FormatFab + di-Fc
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusDiscontinued
100% SI Structure4k3j:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2010
Year Recommended2011
CompaniesChugai Pharmaceutical;Genentech
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedBreast cancer;Colorectal cancer;Gastric cancer;Glioblastoma;Liver cancer;Non-small cell lung cancer;Solid tumours
Development Techna